- 英文名称
- Solcitinib
- 分子式
- C22H23N5O2
- 分子量
- 389.45
- 中文别名
- N-(5-(4-(3,3-二甲基氮杂环丁烷-1-羰基)苯基)-[1,2,4]三唑并[1,5-a]吡啶-2-基)环丙烷甲酰胺; N-(5-(4-(3,3-二甲基氮杂环丁烷-1-羰基)苯基)-[1,2,4]三唑[1,5-A]吡啶-2-基)环丙烷甲酰胺; N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide; N-(5-{4-[(3,3-Dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide; N-(5-{4-[(3,3-dimethylazetidin-1-yl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide; solcitinibum; GLPG0778; GSK2586184A; G154578; GLPG-0778; GSK-2586184; GSK2586184; N-[5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide; N-{5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl}cyclopropanecarboxamide; cyclopropanecarboxylic acid {5-[4-(3,3-dimethyl-azetidine-1-carbonyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl}-amide; N-(5-(4-((3,3-DIMETHYL-1-AZETIDINYL)CARBONYL)PHENYL)(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)CYCLOPROPANECARBOXAMIDE; N-(5-(4-((3,3-dimethylazetidin-1-yl)carbonyl)phenyl)(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide
- 用途
- 化学合成;作为JAK1、JAK2、JAK3、TYK2等靶点的抑制剂,对JAK2、JAK3、TYK2、JAK1的抑制活性在8-9 nM范围。